Business Description
![Monopar Therapeutics Inc Monopar Therapeutics Inc logo](https://static.gurufocus.com/logos/0C0000BO79.png?14)
Monopar Therapeutics Inc
NAICS : 325411
SIC : 2834
ISIN : US61023L1089
Description
Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of?Validive?for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicin?for the treatment?of soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.
Financial Strength
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.84 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 3/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -2.5 | |||||
3-Year EPS without NRI Growth Rate | -1.1 | |||||
3-Year FCF Growth Rate | -10.2 | |||||
3-Year Book Growth Rate | -35.1 |
Momentum Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 37.54 | |||||
9-Day RSI | 43.65 | |||||
14-Day RSI | 46.86 | |||||
6-1 Month Momentum % | 65.16 | |||||
12-1 Month Momentum % | -28.53 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 6.21 | |||||
Quick Ratio | 6.21 | |||||
Cash Ratio | 6.13 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -9.2 | |||||
Shareholder Yield % | -34.3 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -104.35 | |||||
ROA % | -80.91 | |||||
ROIC % | -21700 | |||||
ROC (Joel Greenblatt) % | -21700 | |||||
ROCE % | -110.12 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 1.67 | |||||
Price-to-Tangible-Book | 1.67 | |||||
EV-to-EBIT | -0.71 | |||||
EV-to-EBITDA | -0.71 | |||||
EV-to-FCF | -0.79 | |||||
Price-to-Net-Current-Asset-Value | 1.67 | |||||
Price-to-Net-Cash | 1.71 | |||||
Earnings Yield (Greenblatt) % | -140.85 | |||||
FCF Yield % | -57.52 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:MNPR
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Monopar Therapeutics Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | |||
EPS (TTM) ($) | -0.52 | ||
Beta | 1.24 | ||
Volatility % | 164.6 | ||
14-Day RSI | 46.86 | ||
14-Day ATR ($) | 0.083075 | ||
20-Day SMA ($) | 0.800105 | ||
12-1 Month Momentum % | -28.53 | ||
52-Week Range ($) | 0.2739 - 1.73 | ||
Shares Outstanding (Mil) | 17.48 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Monopar Therapeutics Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Monopar Therapeutics Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Monopar Therapeutics Inc Frequently Asked Questions
What is Monopar Therapeutics Inc(MNPR)'s stock price today?
The current price of MNPR is $0.72. The 52 week high of MNPR is $1.73 and 52 week low is $0.27.
When is next earnings date of Monopar Therapeutics Inc(MNPR)?
The next earnings date of Monopar Therapeutics Inc(MNPR) is 2024-08-09 Est..
Does Monopar Therapeutics Inc(MNPR) pay dividends? If so, how much?
Monopar Therapeutics Inc(MNPR) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |